Skip to content

Breathing Strength and COPD: How Diaphragm Health Affects Treatment Results

Diaphragmatic Dysfunction: Impact on NIV Usage during COPD Exacerbations (DINO) - DINO

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/12/060823
Enrollment
30
Registered
2023-12-27
Start date
Unknown
Completion date
Unknown
Last updated
2024-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J99- Respiratory disorders in diseasesclassified elsewhere

Interventions

Intervention1: NIL: NIL Control Intervention1: NIL: NIL

Sponsors

Dr Amrita Bhattacharya
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: i.Patients admitted with acidotic, hypercarbic COPD exacerbation. ii. Age > 18 yrs and = 8yrs.

Exclusion criteria

Exclusion criteria: 1.Pre-existing diaphragmatic dysfunction or neuromuscular diseases affecting diaphragmatic function 2. Pregnant women 3. Contraindications to the sniff test or absence of a window on ultrasound examination 4. Inability to sit up for the fluoroscopy or USG examination 5. Patients who are frail, bedbound, end stage organ damage, malignancy 6.NIVO score being either too low (0–2) or too high (7 to 9).

Design outcomes

Primary

MeasureTime frame
The correlation between diaphragm dysfunction as assessed by ultrasonographically measured excursion and fluoroscopy-measured excursion during a sniff maneuver at three key time points: •Upon admission •At ICU discharge •At a 3-month follow-up Timepoint: •Upon admission •At ICU discharge •At a 3-month follow-up

Secondary

MeasureTime frame
1. The difference in total duration of NIV usage between patients with and without diaphragm dysfunction 2.the incidence of NIV failure 3. Mortality rates 4. MRCD dyspnea scores 5. levels of functional impairmentTimepoint: At 3 months post discharge

Countries

India

Contacts

Public ContactDr Amrita Bhattacharya

The Calcutta Medical Research Institute

pupuldoc@gmail.com03340904090

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026